We found that IGFBP-3 circulating levels at the end of the study were higher in subjects with a family history of CRC compared to subjects without a family history of CRC (p = 0.04 adjusted for baseline, age, and treatment arms, Supplementary Figure S3). The gene discussed is IGFBP3; the disease is colorectal carcinoma.